Clinical Trial Update: Nab-Paclitaxel to Paclitaxel in Advanced Urothelial Cancer Progressing on or After Platinum Containing Regimen. [Phase 2]

View source ↗

Summary

Phase 2 trial comparing Nab-Paclitaxel to Paclitaxel in advanced urothelial cancer progressing after platinum therapy has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Cancer

Drugs mentioned

• Nab-paclitaxel (paclitaxel protein-bound)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Canadian Cancer Trials Group | Conditions: Urothelial Cancer | Phase 2 | Status: COMPLETED | Results posted: 2020-01-18